Every week, another headline screams that AI is transforming everything. Move fast. Disrupt. Ship it.

And every week, the people who actually build products in regulated industries close the tab and get back to work. Because in their (your?) world, "move fast and break things" means a rejected FDA submission, a failed bank audit, or a compliance violation that makes the evening news.

There is a massive gap between the AI conversation happening in tech and the AI reality in regulated industries like medtech, pharma, financial services, energy, government, legal, insurance, and healthcare delivery.

The tech world has a thousand newsletters covering the latest models, funding rounds, and startup launches. Regulated industries have consultant whitepapers that cost $5,000 and law firm memos written for other lawyers.

Nothing in between. Nothing for the quality director who needs to understand how AI fits into 21 CFR. Nothing for the compliance officer evaluating whether a large language model creates new risk under existing frameworks. Nothing for the VP of engineering who knows AI could cut thousands of hours of manual work but can't figure out how to get it past legal.

That gap is why The Regulated Machine exists.

What we actually are

A weekly intelligence brief on AI adoption in industries where the stakes are too high for guesswork.

Every issue delivers:

  • What happened?” the most important AI developments affecting regulated industries, distilled from primary sources (not rewritten press releases)

  • What it means?” practical translation of policy, frameworks, and guidance into language practitioners can act on

  • What to do?” concrete steps, not theory. Playbooks, not platitudes.

We cover medtech, pharma, financial services, energy, government, legal, insurance, and healthcare delivery. Not because breadth sounds impressive, but because the best ideas in regulated AI are cross-pollinating between industries right now, and nobody is connecting the dots.

The bank that built model validation for credit scoring? That framework maps directly to clinical decision support under the FDA's AI/ML action plan. The energy company that achieved NERC CIP compliance while deploying AI-powered grid monitoring? Their documentation approach is what pharma companies need for GxP validation.

These connections are invisible if you only read your industry's trade press. They're obvious once someone shows them to you.

That's what we do.

Who's behind this

The Regulated Machine was born out of frustration.

Frustration watching AI deliver real gains in tech while regulated industries struggled to adopt even basic automation. Frustration sitting in rooms where everyone agreed AI could streamline document review, accelerate submissions, reduce human error and then watching the same conversation stall for months over compliance ambiguity. Frustration reading the hundredth "AI will revolutionize healthcare" headline from someone who has never explained a software validation protocol to an auditor.

We're obsessed with efficiency; with finding the improvements hiding inside workflows that haven't changed in 20 years. AI is the biggest unlock for that in our lifetimes. But in regulated industries, the path from "this could work" to "this is in production" runs through a maze of frameworks, guidance documents, and institutional caution that most AI coverage completely ignores.

We've lived that maze. We got tired of waiting for someone else to write the guide.

What we believe

AI adoption in regulated industries isn't slow because people are scared. It's slow because the guidance is ambiguous, the risks are real, and the playbooks don't exist yet. We're here to help write them.

The adoption gap is fixable. Healthcare firms used AI at a rate of just 8.3% in 2025, compared to 15.1% in education and 11.6% in finance and insurance, according to U.S. Census Bureau Business Trends and Outlook Survey data published in JAMA, 2025. The technology isn't the bottleneck. The translation layer between "what AI can do" and "what regulators will accept" barely exists. That's what we're building.

Cross-industry thinking is an unfair advantage. The regulated world is siloed. Medtech doesn't talk to finserv. Energy doesn't talk to pharma. But the compliance challenges are structurally similar. Every issue connects insights across boundaries that the industry press pretends don't exist.

Accuracy is non-negotiable. In regulated industries, the cost of bad information is measured in warning letters, failed audits, and delayed products. We cite primary sources. We distinguish fact from interpretation. We'd rather publish nothing than publish something wrong.

This problem is bigger than any one newsletter. The people navigating AI adoption in regulated industries are scattered across companies, industries, and continents — all solving variations of the same problem in isolation. Bringing them together changes everything.

What's coming

This is Issue #0. The starting gun.

Starting next week, you'll get one issue every Tuesday morning with the intelligence you need to move AI forward in your organization without the hype, without the hand-waving, and without the $500/hour consulting fee.

First up: How Wall Street deployed AI to slash document processing time and what every regulated industry still doing manual review can steal from their playbook.

We're building more than a newsletter. The playbooks that don't exist yet? We're writing them. The community of people solving these problems in isolation? We're building that too. More soon.

If you work in a regulated industry and you're trying to figure out AI, you're in the right place.

Welcome to The Regulated Machine.

The Regulated Machine publishes every Tuesday. Subscribe’

Keep Reading